nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—CYP2D6—Gefitinib—lung cancer	0.0667	0.125	CbGbCtD
Bisoprolol—CYP2D6—Vinorelbine—lung cancer	0.0514	0.096	CbGbCtD
Bisoprolol—CYP3A4—Topotecan—lung cancer	0.0463	0.0866	CbGbCtD
Bisoprolol—CYP3A4—Gefitinib—lung cancer	0.0424	0.0792	CbGbCtD
Bisoprolol—CYP3A4—Teniposide—lung cancer	0.0411	0.0768	CbGbCtD
Bisoprolol—CYP2D6—Erlotinib—lung cancer	0.0394	0.0737	CbGbCtD
Bisoprolol—CYP3A4—Vinorelbine—lung cancer	0.0327	0.061	CbGbCtD
Bisoprolol—CYP2D6—Vinblastine—lung cancer	0.0316	0.0592	CbGbCtD
Bisoprolol—CYP3A4—Crizotinib—lung cancer	0.026	0.0486	CbGbCtD
Bisoprolol—CYP3A4—Erlotinib—lung cancer	0.0251	0.0469	CbGbCtD
Bisoprolol—CYP3A4—Paclitaxel—lung cancer	0.0229	0.0429	CbGbCtD
Bisoprolol—CYP3A4—Irinotecan—lung cancer	0.0226	0.0423	CbGbCtD
Bisoprolol—CYP3A4—Vinblastine—lung cancer	0.0201	0.0376	CbGbCtD
Bisoprolol—CYP2D6—Doxorubicin—lung cancer	0.0194	0.0364	CbGbCtD
Bisoprolol—CYP3A4—Etoposide—lung cancer	0.0181	0.0339	CbGbCtD
Bisoprolol—CYP3A4—Docetaxel—lung cancer	0.0166	0.031	CbGbCtD
Bisoprolol—CYP3A4—Doxorubicin—lung cancer	0.0124	0.0231	CbGbCtD
Bisoprolol—Chlorphenesin—PTGS2—lung cancer	0.000488	0.235	CrCbGaD
Bisoprolol—Atenolol—ABCB1—lung cancer	0.000415	0.2	CrCbGaD
Bisoprolol—Acebutolol—ABCB1—lung cancer	0.000383	0.184	CrCbGaD
Bisoprolol—Metoprolol—ABCB1—lung cancer	0.000324	0.155	CrCbGaD
Bisoprolol—Propranolol—CYP1A1—lung cancer	0.000307	0.148	CrCbGaD
Bisoprolol—Propranolol—ABCB1—lung cancer	0.000163	0.0785	CrCbGaD
Bisoprolol—Paraesthesia—Etoposide—lung cancer	0.00016	0.000404	CcSEcCtD
Bisoprolol—Loss of consciousness—Docetaxel—lung cancer	0.00016	0.000403	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000159	0.000402	CcSEcCtD
Bisoprolol—Dyspnoea—Etoposide—lung cancer	0.000159	0.000402	CcSEcCtD
Bisoprolol—Somnolence—Etoposide—lung cancer	0.000159	0.0004	CcSEcCtD
Bisoprolol—Cough—Docetaxel—lung cancer	0.000159	0.0004	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Methotrexate—lung cancer	0.000158	0.0004	CcSEcCtD
Bisoprolol—Insomnia—Paclitaxel—lung cancer	0.000158	0.000399	CcSEcCtD
Bisoprolol—Hypersensitivity—Irinotecan—lung cancer	0.000158	0.000399	CcSEcCtD
Bisoprolol—Paraesthesia—Paclitaxel—lung cancer	0.000157	0.000397	CcSEcCtD
Bisoprolol—Bronchitis—Doxorubicin—lung cancer	0.000157	0.000395	CcSEcCtD
Bisoprolol—Agranulocytosis—Methotrexate—lung cancer	0.000156	0.000395	CcSEcCtD
Bisoprolol—Dyspnoea—Paclitaxel—lung cancer	0.000156	0.000394	CcSEcCtD
Bisoprolol—Somnolence—Paclitaxel—lung cancer	0.000156	0.000393	CcSEcCtD
Bisoprolol—Arthralgia—Docetaxel—lung cancer	0.000155	0.000391	CcSEcCtD
Bisoprolol—Chest pain—Docetaxel—lung cancer	0.000155	0.000391	CcSEcCtD
Bisoprolol—Myalgia—Docetaxel—lung cancer	0.000155	0.000391	CcSEcCtD
Bisoprolol—Nausea—Vinorelbine—lung cancer	0.000154	0.00039	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Etoposide—lung cancer	0.000154	0.000389	CcSEcCtD
Bisoprolol—Dyspepsia—Paclitaxel—lung cancer	0.000154	0.000389	CcSEcCtD
Bisoprolol—Body temperature increased—Cisplatin—lung cancer	0.000154	0.000389	CcSEcCtD
Bisoprolol—Asthenia—Irinotecan—lung cancer	0.000154	0.000389	CcSEcCtD
Bisoprolol—Fatigue—Etoposide—lung cancer	0.000154	0.000388	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000154	0.000388	CcSEcCtD
Bisoprolol—Constipation—Etoposide—lung cancer	0.000153	0.000385	CcSEcCtD
Bisoprolol—Pain—Etoposide—lung cancer	0.000153	0.000385	CcSEcCtD
Bisoprolol—Dry mouth—Docetaxel—lung cancer	0.000151	0.000382	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000151	0.000381	CcSEcCtD
Bisoprolol—Fatigue—Paclitaxel—lung cancer	0.000151	0.000381	CcSEcCtD
Bisoprolol—Hepatitis—Methotrexate—lung cancer	0.00015	0.00038	CcSEcCtD
Bisoprolol—Asthenia—Gemcitabine—lung cancer	0.00015	0.000378	CcSEcCtD
Bisoprolol—Constipation—Paclitaxel—lung cancer	0.00015	0.000378	CcSEcCtD
Bisoprolol—Pain—Paclitaxel—lung cancer	0.00015	0.000378	CcSEcCtD
Bisoprolol—Confusional state—Docetaxel—lung cancer	0.00015	0.000377	CcSEcCtD
Bisoprolol—Pharyngitis—Methotrexate—lung cancer	0.000149	0.000377	CcSEcCtD
Bisoprolol—Photosensitivity reaction—Doxorubicin—lung cancer	0.000149	0.000375	CcSEcCtD
Bisoprolol—Oedema—Docetaxel—lung cancer	0.000148	0.000374	CcSEcCtD
Bisoprolol—Weight increased—Doxorubicin—lung cancer	0.000148	0.000374	CcSEcCtD
Bisoprolol—Pruritus—Gemcitabine—lung cancer	0.000148	0.000373	CcSEcCtD
Bisoprolol—Infection—Docetaxel—lung cancer	0.000147	0.000372	CcSEcCtD
Bisoprolol—Feeling abnormal—Etoposide—lung cancer	0.000147	0.000371	CcSEcCtD
Bisoprolol—Diarrhoea—Irinotecan—lung cancer	0.000147	0.000371	CcSEcCtD
Bisoprolol—Pneumonia—Doxorubicin—lung cancer	0.000146	0.000368	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Etoposide—lung cancer	0.000146	0.000368	CcSEcCtD
Bisoprolol—Shock—Docetaxel—lung cancer	0.000146	0.000368	CcSEcCtD
Bisoprolol—Nervous system disorder—Docetaxel—lung cancer	0.000145	0.000367	CcSEcCtD
Bisoprolol—Thrombocytopenia—Docetaxel—lung cancer	0.000145	0.000367	CcSEcCtD
Bisoprolol—Drowsiness—Doxorubicin—lung cancer	0.000145	0.000366	CcSEcCtD
Bisoprolol—Visual impairment—Methotrexate—lung cancer	0.000145	0.000366	CcSEcCtD
Bisoprolol—Tachycardia—Docetaxel—lung cancer	0.000145	0.000365	CcSEcCtD
Bisoprolol—Feeling abnormal—Paclitaxel—lung cancer	0.000144	0.000364	CcSEcCtD
Bisoprolol—Skin disorder—Docetaxel—lung cancer	0.000144	0.000364	CcSEcCtD
Bisoprolol—Hypersensitivity—Cisplatin—lung cancer	0.000143	0.000362	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Paclitaxel—lung cancer	0.000143	0.000361	CcSEcCtD
Bisoprolol—Diarrhoea—Gemcitabine—lung cancer	0.000143	0.000361	CcSEcCtD
Bisoprolol—Dizziness—Irinotecan—lung cancer	0.000142	0.000358	CcSEcCtD
Bisoprolol—Urticaria—Etoposide—lung cancer	0.000142	0.000358	CcSEcCtD
Bisoprolol—Abdominal pain—Etoposide—lung cancer	0.000141	0.000356	CcSEcCtD
Bisoprolol—Body temperature increased—Etoposide—lung cancer	0.000141	0.000356	CcSEcCtD
Bisoprolol—Conjunctivitis—Doxorubicin—lung cancer	0.000141	0.000356	CcSEcCtD
Bisoprolol—Urinary tract infection—Doxorubicin—lung cancer	0.000141	0.000356	CcSEcCtD
Bisoprolol—Eye disorder—Methotrexate—lung cancer	0.000141	0.000355	CcSEcCtD
Bisoprolol—Tinnitus—Methotrexate—lung cancer	0.00014	0.000354	CcSEcCtD
Bisoprolol—Asthenia—Cisplatin—lung cancer	0.00014	0.000353	CcSEcCtD
Bisoprolol—Cardiac disorder—Methotrexate—lung cancer	0.00014	0.000352	CcSEcCtD
Bisoprolol—Sweating—Doxorubicin—lung cancer	0.000139	0.000351	CcSEcCtD
Bisoprolol—Urticaria—Paclitaxel—lung cancer	0.000139	0.000351	CcSEcCtD
Bisoprolol—Hypotension—Docetaxel—lung cancer	0.000139	0.00035	CcSEcCtD
Bisoprolol—Body temperature increased—Paclitaxel—lung cancer	0.000138	0.000349	CcSEcCtD
Bisoprolol—Abdominal pain—Paclitaxel—lung cancer	0.000138	0.000349	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Doxorubicin—lung cancer	0.000137	0.000346	CcSEcCtD
Bisoprolol—Angiopathy—Methotrexate—lung cancer	0.000136	0.000345	CcSEcCtD
Bisoprolol—Vomiting—Irinotecan—lung cancer	0.000136	0.000344	CcSEcCtD
Bisoprolol—Sinusitis—Doxorubicin—lung cancer	0.000136	0.000344	CcSEcCtD
Bisoprolol—Mediastinal disorder—Methotrexate—lung cancer	0.000136	0.000342	CcSEcCtD
Bisoprolol—Agranulocytosis—Doxorubicin—lung cancer	0.000135	0.000342	CcSEcCtD
Bisoprolol—Rash—Irinotecan—lung cancer	0.000135	0.000341	CcSEcCtD
Bisoprolol—Dermatitis—Irinotecan—lung cancer	0.000135	0.000341	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000135	0.000341	CcSEcCtD
Bisoprolol—Headache—Irinotecan—lung cancer	0.000134	0.000339	CcSEcCtD
Bisoprolol—Insomnia—Docetaxel—lung cancer	0.000134	0.000339	CcSEcCtD
Bisoprolol—Diarrhoea—Cisplatin—lung cancer	0.000133	0.000336	CcSEcCtD
Bisoprolol—Paraesthesia—Docetaxel—lung cancer	0.000133	0.000336	CcSEcCtD
Bisoprolol—Alopecia—Methotrexate—lung cancer	0.000133	0.000336	CcSEcCtD
Bisoprolol—Vomiting—Gemcitabine—lung cancer	0.000133	0.000335	CcSEcCtD
Bisoprolol—Bradycardia—Doxorubicin—lung cancer	0.000133	0.000335	CcSEcCtD
Bisoprolol—Dyspnoea—Docetaxel—lung cancer	0.000132	0.000334	CcSEcCtD
Bisoprolol—Somnolence—Docetaxel—lung cancer	0.000132	0.000333	CcSEcCtD
Bisoprolol—Mental disorder—Methotrexate—lung cancer	0.000132	0.000333	CcSEcCtD
Bisoprolol—Rash—Gemcitabine—lung cancer	0.000132	0.000333	CcSEcCtD
Bisoprolol—Dermatitis—Gemcitabine—lung cancer	0.000132	0.000332	CcSEcCtD
Bisoprolol—Hypersensitivity—Etoposide—lung cancer	0.000131	0.000332	CcSEcCtD
Bisoprolol—Erythema—Methotrexate—lung cancer	0.000131	0.000331	CcSEcCtD
Bisoprolol—Headache—Gemcitabine—lung cancer	0.000131	0.00033	CcSEcCtD
Bisoprolol—Rhinitis—Doxorubicin—lung cancer	0.000131	0.00033	CcSEcCtD
Bisoprolol—Dyspepsia—Docetaxel—lung cancer	0.000131	0.00033	CcSEcCtD
Bisoprolol—Hepatitis—Doxorubicin—lung cancer	0.00013	0.000329	CcSEcCtD
Bisoprolol—Hypoaesthesia—Doxorubicin—lung cancer	0.00013	0.000327	CcSEcCtD
Bisoprolol—Pharyngitis—Doxorubicin—lung cancer	0.000129	0.000326	CcSEcCtD
Bisoprolol—Hypersensitivity—Paclitaxel—lung cancer	0.000129	0.000325	CcSEcCtD
Bisoprolol—Oedema peripheral—Doxorubicin—lung cancer	0.000128	0.000324	CcSEcCtD
Bisoprolol—Dysgeusia—Methotrexate—lung cancer	0.000128	0.000324	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Docetaxel—lung cancer	0.000128	0.000323	CcSEcCtD
Bisoprolol—Asthenia—Etoposide—lung cancer	0.000128	0.000323	CcSEcCtD
Bisoprolol—Connective tissue disorder—Doxorubicin—lung cancer	0.000128	0.000323	CcSEcCtD
Bisoprolol—Fatigue—Docetaxel—lung cancer	0.000128	0.000323	CcSEcCtD
Bisoprolol—Nausea—Irinotecan—lung cancer	0.000127	0.000322	CcSEcCtD
Bisoprolol—Constipation—Docetaxel—lung cancer	0.000127	0.00032	CcSEcCtD
Bisoprolol—Pain—Docetaxel—lung cancer	0.000127	0.00032	CcSEcCtD
Bisoprolol—Back pain—Methotrexate—lung cancer	0.000127	0.00032	CcSEcCtD
Bisoprolol—Pruritus—Etoposide—lung cancer	0.000126	0.000319	CcSEcCtD
Bisoprolol—Visual impairment—Doxorubicin—lung cancer	0.000126	0.000317	CcSEcCtD
Bisoprolol—Asthenia—Paclitaxel—lung cancer	0.000126	0.000317	CcSEcCtD
Bisoprolol—Nausea—Gemcitabine—lung cancer	0.000124	0.000313	CcSEcCtD
Bisoprolol—Vomiting—Cisplatin—lung cancer	0.000124	0.000313	CcSEcCtD
Bisoprolol—Pruritus—Paclitaxel—lung cancer	0.000124	0.000312	CcSEcCtD
Bisoprolol—Rash—Cisplatin—lung cancer	0.000123	0.00031	CcSEcCtD
Bisoprolol—Dermatitis—Cisplatin—lung cancer	0.000123	0.00031	CcSEcCtD
Bisoprolol—Feeling abnormal—Docetaxel—lung cancer	0.000122	0.000308	CcSEcCtD
Bisoprolol—Diarrhoea—Etoposide—lung cancer	0.000122	0.000308	CcSEcCtD
Bisoprolol—Eye disorder—Doxorubicin—lung cancer	0.000122	0.000307	CcSEcCtD
Bisoprolol—Ill-defined disorder—Methotrexate—lung cancer	0.000122	0.000307	CcSEcCtD
Bisoprolol—Tinnitus—Doxorubicin—lung cancer	0.000121	0.000307	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Docetaxel—lung cancer	0.000121	0.000306	CcSEcCtD
Bisoprolol—Flushing—Doxorubicin—lung cancer	0.000121	0.000305	CcSEcCtD
Bisoprolol—Cardiac disorder—Doxorubicin—lung cancer	0.000121	0.000305	CcSEcCtD
Bisoprolol—Diarrhoea—Paclitaxel—lung cancer	0.00012	0.000302	CcSEcCtD
Bisoprolol—Angiopathy—Doxorubicin—lung cancer	0.000118	0.000298	CcSEcCtD
Bisoprolol—Malaise—Methotrexate—lung cancer	0.000118	0.000298	CcSEcCtD
Bisoprolol—Dizziness—Etoposide—lung cancer	0.000118	0.000298	CcSEcCtD
Bisoprolol—Vertigo—Methotrexate—lung cancer	0.000118	0.000297	CcSEcCtD
Bisoprolol—Mediastinal disorder—Doxorubicin—lung cancer	0.000117	0.000296	CcSEcCtD
Bisoprolol—Body temperature increased—Docetaxel—lung cancer	0.000117	0.000296	CcSEcCtD
Bisoprolol—Abdominal pain—Docetaxel—lung cancer	0.000117	0.000296	CcSEcCtD
Bisoprolol—Arrhythmia—Doxorubicin—lung cancer	0.000116	0.000294	CcSEcCtD
Bisoprolol—Dizziness—Paclitaxel—lung cancer	0.000116	0.000292	CcSEcCtD
Bisoprolol—Nausea—Cisplatin—lung cancer	0.000116	0.000292	CcSEcCtD
Bisoprolol—Alopecia—Doxorubicin—lung cancer	0.000115	0.000291	CcSEcCtD
Bisoprolol—Cough—Methotrexate—lung cancer	0.000114	0.000288	CcSEcCtD
Bisoprolol—Mental disorder—Doxorubicin—lung cancer	0.000114	0.000288	CcSEcCtD
Bisoprolol—Vomiting—Etoposide—lung cancer	0.000113	0.000286	CcSEcCtD
Bisoprolol—Erythema—Doxorubicin—lung cancer	0.000113	0.000286	CcSEcCtD
Bisoprolol—Rash—Etoposide—lung cancer	0.000113	0.000284	CcSEcCtD
Bisoprolol—Dermatitis—Etoposide—lung cancer	0.000112	0.000284	CcSEcCtD
Bisoprolol—Headache—Etoposide—lung cancer	0.000112	0.000282	CcSEcCtD
Bisoprolol—Chest pain—Methotrexate—lung cancer	0.000111	0.000281	CcSEcCtD
Bisoprolol—Arthralgia—Methotrexate—lung cancer	0.000111	0.000281	CcSEcCtD
Bisoprolol—Myalgia—Methotrexate—lung cancer	0.000111	0.000281	CcSEcCtD
Bisoprolol—Vomiting—Paclitaxel—lung cancer	0.000111	0.000281	CcSEcCtD
Bisoprolol—Dysgeusia—Doxorubicin—lung cancer	0.000111	0.00028	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000111	0.00028	CcSEcCtD
Bisoprolol—Rash—Paclitaxel—lung cancer	0.00011	0.000278	CcSEcCtD
Bisoprolol—Dermatitis—Paclitaxel—lung cancer	0.00011	0.000278	CcSEcCtD
Bisoprolol—Discomfort—Methotrexate—lung cancer	0.00011	0.000278	CcSEcCtD
Bisoprolol—Back pain—Doxorubicin—lung cancer	0.00011	0.000277	CcSEcCtD
Bisoprolol—Headache—Paclitaxel—lung cancer	0.00011	0.000277	CcSEcCtD
Bisoprolol—Hypersensitivity—Docetaxel—lung cancer	0.000109	0.000276	CcSEcCtD
Bisoprolol—Muscle spasms—Doxorubicin—lung cancer	0.000109	0.000275	CcSEcCtD
Bisoprolol—Confusional state—Methotrexate—lung cancer	0.000108	0.000272	CcSEcCtD
Bisoprolol—Asthenia—Docetaxel—lung cancer	0.000106	0.000269	CcSEcCtD
Bisoprolol—Infection—Methotrexate—lung cancer	0.000106	0.000268	CcSEcCtD
Bisoprolol—Nausea—Etoposide—lung cancer	0.000106	0.000268	CcSEcCtD
Bisoprolol—Ill-defined disorder—Doxorubicin—lung cancer	0.000105	0.000266	CcSEcCtD
Bisoprolol—Pruritus—Docetaxel—lung cancer	0.000105	0.000265	CcSEcCtD
Bisoprolol—Nervous system disorder—Methotrexate—lung cancer	0.000105	0.000265	CcSEcCtD
Bisoprolol—Thrombocytopenia—Methotrexate—lung cancer	0.000105	0.000264	CcSEcCtD
Bisoprolol—Agitation—Doxorubicin—lung cancer	0.000104	0.000263	CcSEcCtD
Bisoprolol—Nausea—Paclitaxel—lung cancer	0.000104	0.000262	CcSEcCtD
Bisoprolol—Skin disorder—Methotrexate—lung cancer	0.000104	0.000262	CcSEcCtD
Bisoprolol—Hyperhidrosis—Methotrexate—lung cancer	0.000103	0.000261	CcSEcCtD
Bisoprolol—Malaise—Doxorubicin—lung cancer	0.000102	0.000258	CcSEcCtD
Bisoprolol—Vertigo—Doxorubicin—lung cancer	0.000102	0.000257	CcSEcCtD
Bisoprolol—Syncope—Doxorubicin—lung cancer	0.000102	0.000257	CcSEcCtD
Bisoprolol—Diarrhoea—Docetaxel—lung cancer	0.000101	0.000256	CcSEcCtD
Bisoprolol—Palpitations—Doxorubicin—lung cancer	0.0001	0.000253	CcSEcCtD
Bisoprolol—Hypotension—Methotrexate—lung cancer	9.99e-05	0.000252	CcSEcCtD
Bisoprolol—Loss of consciousness—Doxorubicin—lung cancer	9.97e-05	0.000252	CcSEcCtD
Bisoprolol—Cough—Doxorubicin—lung cancer	9.89e-05	0.00025	CcSEcCtD
Bisoprolol—Dizziness—Docetaxel—lung cancer	9.81e-05	0.000248	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Methotrexate—lung cancer	9.74e-05	0.000246	CcSEcCtD
Bisoprolol—Insomnia—Methotrexate—lung cancer	9.67e-05	0.000244	CcSEcCtD
Bisoprolol—Chest pain—Doxorubicin—lung cancer	9.65e-05	0.000244	CcSEcCtD
Bisoprolol—Arthralgia—Doxorubicin—lung cancer	9.65e-05	0.000244	CcSEcCtD
Bisoprolol—Myalgia—Doxorubicin—lung cancer	9.65e-05	0.000244	CcSEcCtD
Bisoprolol—Anxiety—Doxorubicin—lung cancer	9.62e-05	0.000243	CcSEcCtD
Bisoprolol—Paraesthesia—Methotrexate—lung cancer	9.6e-05	0.000242	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	9.59e-05	0.000242	CcSEcCtD
Bisoprolol—Discomfort—Doxorubicin—lung cancer	9.54e-05	0.000241	CcSEcCtD
Bisoprolol—Dyspnoea—Methotrexate—lung cancer	9.53e-05	0.000241	CcSEcCtD
Bisoprolol—Somnolence—Methotrexate—lung cancer	9.5e-05	0.00024	CcSEcCtD
Bisoprolol—Dry mouth—Doxorubicin—lung cancer	9.44e-05	0.000238	CcSEcCtD
Bisoprolol—Vomiting—Docetaxel—lung cancer	9.43e-05	0.000238	CcSEcCtD
Bisoprolol—Dyspepsia—Methotrexate—lung cancer	9.41e-05	0.000238	CcSEcCtD
Bisoprolol—Rash—Docetaxel—lung cancer	9.35e-05	0.000236	CcSEcCtD
Bisoprolol—Dermatitis—Docetaxel—lung cancer	9.34e-05	0.000236	CcSEcCtD
Bisoprolol—Confusional state—Doxorubicin—lung cancer	9.33e-05	0.000236	CcSEcCtD
Bisoprolol—Headache—Docetaxel—lung cancer	9.29e-05	0.000235	CcSEcCtD
Bisoprolol—Oedema—Doxorubicin—lung cancer	9.25e-05	0.000234	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Methotrexate—lung cancer	9.23e-05	0.000233	CcSEcCtD
Bisoprolol—Fatigue—Methotrexate—lung cancer	9.21e-05	0.000233	CcSEcCtD
Bisoprolol—Infection—Doxorubicin—lung cancer	9.19e-05	0.000232	CcSEcCtD
Bisoprolol—Pain—Methotrexate—lung cancer	9.14e-05	0.000231	CcSEcCtD
Bisoprolol—Shock—Doxorubicin—lung cancer	9.1e-05	0.00023	CcSEcCtD
Bisoprolol—Nervous system disorder—Doxorubicin—lung cancer	9.08e-05	0.000229	CcSEcCtD
Bisoprolol—Thrombocytopenia—Doxorubicin—lung cancer	9.06e-05	0.000229	CcSEcCtD
Bisoprolol—Tachycardia—Doxorubicin—lung cancer	9.03e-05	0.000228	CcSEcCtD
Bisoprolol—Skin disorder—Doxorubicin—lung cancer	8.99e-05	0.000227	CcSEcCtD
Bisoprolol—Hyperhidrosis—Doxorubicin—lung cancer	8.95e-05	0.000226	CcSEcCtD
Bisoprolol—Nausea—Docetaxel—lung cancer	8.81e-05	0.000222	CcSEcCtD
Bisoprolol—Feeling abnormal—Methotrexate—lung cancer	8.81e-05	0.000222	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Methotrexate—lung cancer	8.74e-05	0.000221	CcSEcCtD
Bisoprolol—Hypotension—Doxorubicin—lung cancer	8.65e-05	0.000218	CcSEcCtD
Bisoprolol—Urticaria—Methotrexate—lung cancer	8.49e-05	0.000214	CcSEcCtD
Bisoprolol—Abdominal pain—Methotrexate—lung cancer	8.45e-05	0.000213	CcSEcCtD
Bisoprolol—Body temperature increased—Methotrexate—lung cancer	8.45e-05	0.000213	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Doxorubicin—lung cancer	8.43e-05	0.000213	CcSEcCtD
Bisoprolol—Insomnia—Doxorubicin—lung cancer	8.37e-05	0.000211	CcSEcCtD
Bisoprolol—Paraesthesia—Doxorubicin—lung cancer	8.31e-05	0.00021	CcSEcCtD
Bisoprolol—Dyspnoea—Doxorubicin—lung cancer	8.25e-05	0.000208	CcSEcCtD
Bisoprolol—Somnolence—Doxorubicin—lung cancer	8.23e-05	0.000208	CcSEcCtD
Bisoprolol—Dyspepsia—Doxorubicin—lung cancer	8.15e-05	0.000206	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Doxorubicin—lung cancer	7.99e-05	0.000202	CcSEcCtD
Bisoprolol—Fatigue—Doxorubicin—lung cancer	7.98e-05	0.000201	CcSEcCtD
Bisoprolol—Pain—Doxorubicin—lung cancer	7.91e-05	0.0002	CcSEcCtD
Bisoprolol—Constipation—Doxorubicin—lung cancer	7.91e-05	0.0002	CcSEcCtD
Bisoprolol—Hypersensitivity—Methotrexate—lung cancer	7.87e-05	0.000199	CcSEcCtD
Bisoprolol—Asthenia—Methotrexate—lung cancer	7.67e-05	0.000194	CcSEcCtD
Bisoprolol—Feeling abnormal—Doxorubicin—lung cancer	7.63e-05	0.000193	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Doxorubicin—lung cancer	7.57e-05	0.000191	CcSEcCtD
Bisoprolol—Pruritus—Methotrexate—lung cancer	7.56e-05	0.000191	CcSEcCtD
Bisoprolol—Urticaria—Doxorubicin—lung cancer	7.35e-05	0.000186	CcSEcCtD
Bisoprolol—Abdominal pain—Doxorubicin—lung cancer	7.32e-05	0.000185	CcSEcCtD
Bisoprolol—Body temperature increased—Doxorubicin—lung cancer	7.32e-05	0.000185	CcSEcCtD
Bisoprolol—Diarrhoea—Methotrexate—lung cancer	7.31e-05	0.000185	CcSEcCtD
Bisoprolol—Dizziness—Methotrexate—lung cancer	7.07e-05	0.000178	CcSEcCtD
Bisoprolol—Hypersensitivity—Doxorubicin—lung cancer	6.82e-05	0.000172	CcSEcCtD
Bisoprolol—Vomiting—Methotrexate—lung cancer	6.8e-05	0.000172	CcSEcCtD
Bisoprolol—Rash—Methotrexate—lung cancer	6.74e-05	0.00017	CcSEcCtD
Bisoprolol—Dermatitis—Methotrexate—lung cancer	6.73e-05	0.00017	CcSEcCtD
Bisoprolol—Headache—Methotrexate—lung cancer	6.7e-05	0.000169	CcSEcCtD
Bisoprolol—Asthenia—Doxorubicin—lung cancer	6.64e-05	0.000168	CcSEcCtD
Bisoprolol—Pruritus—Doxorubicin—lung cancer	6.55e-05	0.000165	CcSEcCtD
Bisoprolol—Nausea—Methotrexate—lung cancer	6.35e-05	0.00016	CcSEcCtD
Bisoprolol—Diarrhoea—Doxorubicin—lung cancer	6.33e-05	0.00016	CcSEcCtD
Bisoprolol—Dizziness—Doxorubicin—lung cancer	6.12e-05	0.000154	CcSEcCtD
Bisoprolol—Vomiting—Doxorubicin—lung cancer	5.88e-05	0.000149	CcSEcCtD
Bisoprolol—Rash—Doxorubicin—lung cancer	5.84e-05	0.000147	CcSEcCtD
Bisoprolol—Dermatitis—Doxorubicin—lung cancer	5.83e-05	0.000147	CcSEcCtD
Bisoprolol—Headache—Doxorubicin—lung cancer	5.8e-05	0.000146	CcSEcCtD
Bisoprolol—Nausea—Doxorubicin—lung cancer	5.5e-05	0.000139	CcSEcCtD
Bisoprolol—ADRB1—Signaling Pathways—FLT1—lung cancer	2.85e-05	0.000425	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GSTA3—lung cancer	2.84e-05	0.000425	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—RRM1—lung cancer	2.84e-05	0.000425	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—PIK3CG—lung cancer	2.82e-05	0.000421	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—APP—lung cancer	2.79e-05	0.000416	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NOTCH3—lung cancer	2.79e-05	0.000416	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—FLT1—lung cancer	2.78e-05	0.000416	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—FGF9—lung cancer	2.76e-05	0.000413	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—PIK3CG—lung cancer	2.76e-05	0.000412	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—APP—lung cancer	2.73e-05	0.000407	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NOTCH3—lung cancer	2.73e-05	0.000407	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—FGF9—lung cancer	2.7e-05	0.000404	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—POMC—lung cancer	2.68e-05	0.000401	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—B4GALT5—lung cancer	2.67e-05	0.000399	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—JUNB—lung cancer	2.64e-05	0.000394	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HSD17B10—lung cancer	2.64e-05	0.000394	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—POMC—lung cancer	2.63e-05	0.000392	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GSTA4—lung cancer	2.6e-05	0.000388	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—JUNB—lung cancer	2.58e-05	0.000386	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PIK3CG—lung cancer	2.56e-05	0.000383	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GSTA2—lung cancer	2.53e-05	0.000378	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PIK3CG—lung cancer	2.5e-05	0.000374	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—PIK3CD—lung cancer	2.48e-05	0.00037	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CKB—lung cancer	2.45e-05	0.000366	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GSTA1—lung cancer	2.44e-05	0.000365	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—POMC—lung cancer	2.44e-05	0.000364	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—PIK3CD—lung cancer	2.42e-05	0.000362	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ABCC3—lung cancer	2.42e-05	0.000361	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—STK11—lung cancer	2.4e-05	0.000358	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—POMC—lung cancer	2.38e-05	0.000356	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—IL6R—lung cancer	2.38e-05	0.000355	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—STK11—lung cancer	2.34e-05	0.00035	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—AKR1C1—lung cancer	2.34e-05	0.00035	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—IL6R—lung cancer	2.33e-05	0.000348	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—FOXO3—lung cancer	2.31e-05	0.000345	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GSTM2—lung cancer	2.3e-05	0.000344	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CNDP2—lung cancer	2.3e-05	0.000344	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—UGT1A1—lung cancer	2.27e-05	0.000339	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—MAP2K1—lung cancer	2.27e-05	0.000339	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—FOXO3—lung cancer	2.26e-05	0.000338	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PIK3CD—lung cancer	2.25e-05	0.000336	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—MTMR3—lung cancer	2.24e-05	0.000335	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—MAP2K1—lung cancer	2.22e-05	0.000331	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PIK3CD—lung cancer	2.2e-05	0.000329	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GNG11—lung cancer	2.19e-05	0.000327	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PGAM1—lung cancer	2.18e-05	0.000327	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—AVP—lung cancer	2.17e-05	0.000324	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—PIK3CB—lung cancer	2.16e-05	0.000323	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—AVP—lung cancer	2.12e-05	0.000317	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—PIK3CB—lung cancer	2.11e-05	0.000316	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ALDOA—lung cancer	2.09e-05	0.000312	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IGF1R—lung cancer	2.09e-05	0.000312	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP2A7—lung cancer	2.08e-05	0.000311	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—CXCL8—lung cancer	2.08e-05	0.00031	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HES1—lung cancer	2.05e-05	0.000306	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IGF1R—lung cancer	2.04e-05	0.000305	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SDC4—lung cancer	2.04e-05	0.000305	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—CXCL8—lung cancer	2.03e-05	0.000303	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—NCOA3—lung cancer	2.02e-05	0.000303	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—RAF1—lung cancer	2.01e-05	0.0003	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HES1—lung cancer	2e-05	0.000299	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—IL2—lung cancer	1.98e-05	0.000296	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ADCY1—lung cancer	1.97e-05	0.000294	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ABCG2—lung cancer	1.97e-05	0.000294	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—RAF1—lung cancer	1.97e-05	0.000294	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PIK3CB—lung cancer	1.96e-05	0.000293	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—IL2—lung cancer	1.94e-05	0.00029	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ENO2—lung cancer	1.93e-05	0.000289	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—HPGDS—lung cancer	1.93e-05	0.000289	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.92e-05	0.000287	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PIK3CB—lung cancer	1.92e-05	0.000287	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—CXCL8—lung cancer	1.89e-05	0.000282	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GSTT1—lung cancer	1.87e-05	0.00028	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ERBB3—lung cancer	1.87e-05	0.00028	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GSTA3—lung cancer	1.86e-05	0.000278	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—RRM1—lung cancer	1.86e-05	0.000278	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GCLC—lung cancer	1.85e-05	0.000277	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP2A6—lung cancer	1.85e-05	0.000277	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—CXCL8—lung cancer	1.84e-05	0.000276	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ERBB3—lung cancer	1.83e-05	0.000274	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—IL2—lung cancer	1.8e-05	0.000269	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—TERT—lung cancer	1.8e-05	0.000268	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—IL2—lung cancer	1.76e-05	0.000263	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—TERT—lung cancer	1.76e-05	0.000262	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ENO1—lung cancer	1.76e-05	0.000262	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—B4GALT5—lung cancer	1.75e-05	0.000261	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—FGFR1—lung cancer	1.74e-05	0.00026	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HIF1A—lung cancer	1.72e-05	0.000257	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—FGFR1—lung cancer	1.71e-05	0.000255	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GSTA4—lung cancer	1.7e-05	0.000254	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HIF1A—lung cancer	1.68e-05	0.000251	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—APOA1—lung cancer	1.66e-05	0.000248	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GSTA2—lung cancer	1.66e-05	0.000247	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—KDR—lung cancer	1.64e-05	0.000245	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—APOA1—lung cancer	1.62e-05	0.000242	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—KDR—lung cancer	1.61e-05	0.00024	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GSTA1—lung cancer	1.6e-05	0.000239	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ABCC3—lung cancer	1.58e-05	0.000236	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP2E1—lung cancer	1.57e-05	0.000235	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—NQO1—lung cancer	1.56e-05	0.000233	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—AKR1C1—lung cancer	1.53e-05	0.000229	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PIK3CG—lung cancer	1.51e-05	0.000226	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—APC—lung cancer	1.51e-05	0.000226	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—KIT—lung cancer	1.51e-05	0.000226	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—NRAS—lung cancer	1.51e-05	0.000226	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—EGF—lung cancer	1.49e-05	0.000223	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—UGT1A1—lung cancer	1.49e-05	0.000222	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PIK3CG—lung cancer	1.48e-05	0.000221	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—KIT—lung cancer	1.48e-05	0.000221	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—APC—lung cancer	1.48e-05	0.000221	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—NRAS—lung cancer	1.48e-05	0.000221	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—EGF—lung cancer	1.46e-05	0.000219	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—MAPK3—lung cancer	1.45e-05	0.000216	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—POMC—lung cancer	1.44e-05	0.000215	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GNG11—lung cancer	1.43e-05	0.000214	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—BRAF—lung cancer	1.42e-05	0.000212	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—MAPK3—lung cancer	1.42e-05	0.000212	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—POMC—lung cancer	1.41e-05	0.00021	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IL6R—lung cancer	1.4e-05	0.00021	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—STK11—lung cancer	1.4e-05	0.00021	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CREBBP—lung cancer	1.4e-05	0.00021	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—BRAF—lung cancer	1.39e-05	0.000208	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—EGFR—lung cancer	1.38e-05	0.000206	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IL6R—lung cancer	1.37e-05	0.000205	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CREBBP—lung cancer	1.37e-05	0.000205	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ALDOA—lung cancer	1.36e-05	0.000204	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—EGFR—lung cancer	1.35e-05	0.000201	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MAP2K1—lung cancer	1.34e-05	0.0002	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PIK3CD—lung cancer	1.33e-05	0.000199	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NCOA3—lung cancer	1.32e-05	0.000198	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—PIK3CA—lung cancer	1.32e-05	0.000197	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MAP2K1—lung cancer	1.31e-05	0.000196	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—KRAS—lung cancer	1.3e-05	0.000195	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PIK3CD—lung cancer	1.3e-05	0.000194	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GSTP1—lung cancer	1.3e-05	0.000194	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—PIK3CA—lung cancer	1.29e-05	0.000193	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ADCY1—lung cancer	1.29e-05	0.000192	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ABCG2—lung cancer	1.29e-05	0.000192	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—KRAS—lung cancer	1.27e-05	0.00019	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CAT—lung cancer	1.26e-05	0.000189	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HPGDS—lung cancer	1.26e-05	0.000189	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ENO2—lung cancer	1.26e-05	0.000189	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.25e-05	0.000188	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ABCB1—lung cancer	1.23e-05	0.000184	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GSTT1—lung cancer	1.22e-05	0.000183	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP2A6—lung cancer	1.21e-05	0.000181	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GCLC—lung cancer	1.21e-05	0.000181	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—TYMS—lung cancer	1.21e-05	0.00018	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PIK3CA—lung cancer	1.2e-05	0.000179	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GSTM1—lung cancer	1.19e-05	0.000178	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MDM2—lung cancer	1.19e-05	0.000178	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—RAF1—lung cancer	1.19e-05	0.000177	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ERBB2—lung cancer	1.17e-05	0.000175	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PIK3CA—lung cancer	1.17e-05	0.000175	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MDM2—lung cancer	1.17e-05	0.000174	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—RAF1—lung cancer	1.16e-05	0.000174	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PIK3CB—lung cancer	1.16e-05	0.000173	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MTOR—lung cancer	1.16e-05	0.000173	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ERBB2—lung cancer	1.15e-05	0.000172	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ENO1—lung cancer	1.15e-05	0.000172	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MTOR—lung cancer	1.13e-05	0.000169	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PIK3CB—lung cancer	1.13e-05	0.000169	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP1A1—lung cancer	1.13e-05	0.000169	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ERCC2—lung cancer	1.12e-05	0.000168	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CXCL8—lung cancer	1.11e-05	0.000166	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—HRAS—lung cancer	1.11e-05	0.000165	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CXCL8—lung cancer	1.09e-05	0.000163	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—HRAS—lung cancer	1.08e-05	0.000162	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—AKT1—lung cancer	1.08e-05	0.000161	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CASP3—lung cancer	1.07e-05	0.000159	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IL2—lung cancer	1.06e-05	0.000159	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—IL6—lung cancer	1.06e-05	0.000158	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—AKT1—lung cancer	1.05e-05	0.000157	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CASP3—lung cancer	1.04e-05	0.000156	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IL2—lung cancer	1.04e-05	0.000156	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CCND1—lung cancer	1.04e-05	0.000155	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—IL6—lung cancer	1.04e-05	0.000155	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—JUN—lung cancer	1.04e-05	0.000155	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP2E1—lung cancer	1.03e-05	0.000154	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NQO1—lung cancer	1.02e-05	0.000152	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CCND1—lung cancer	1.01e-05	0.000152	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—JUN—lung cancer	1.01e-05	0.000151	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MMP9—lung cancer	1.01e-05	0.000151	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CDKN1A—lung cancer	1e-05	0.00015	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PTEN—lung cancer	1e-05	0.00015	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MMP9—lung cancer	9.85e-06	0.000147	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CDKN1A—lung cancer	9.82e-06	0.000147	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PTEN—lung cancer	9.8e-06	0.000146	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—AKT1—lung cancer	9.77e-06	0.000146	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—APOA1—lung cancer	9.71e-06	0.000145	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—AKT1—lung cancer	9.56e-06	0.000143	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—EP300—lung cancer	9.55e-06	0.000143	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—EP300—lung cancer	9.34e-06	0.00014	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—SRC—lung cancer	9.29e-06	0.000139	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—STK11—lung cancer	9.18e-06	0.000137	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—SRC—lung cancer	9.08e-06	0.000136	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—VEGFA—lung cancer	9.05e-06	0.000135	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—STAT3—lung cancer	8.96e-06	0.000134	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NRAS—lung cancer	8.93e-06	0.000134	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PIK3CG—lung cancer	8.86e-06	0.000132	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—VEGFA—lung cancer	8.85e-06	0.000132	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—STAT3—lung cancer	8.76e-06	0.000131	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NRAS—lung cancer	8.74e-06	0.000131	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MAPK3—lung cancer	8.56e-06	0.000128	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GSTP1—lung cancer	8.49e-06	0.000127	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—POMC—lung cancer	8.43e-06	0.000126	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MAPK3—lung cancer	8.37e-06	0.000125	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MYC—lung cancer	8.32e-06	0.000124	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CAT—lung cancer	8.26e-06	0.000123	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CREBBP—lung cancer	8.22e-06	0.000123	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MYC—lung cancer	8.14e-06	0.000122	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—EGFR—lung cancer	8.14e-06	0.000122	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ABCB1—lung cancer	8.04e-06	0.00012	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—EGFR—lung cancer	7.96e-06	0.000119	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—TYMS—lung cancer	7.89e-06	0.000118	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GSTM1—lung cancer	7.8e-06	0.000117	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PIK3CD—lung cancer	7.79e-06	0.000116	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—KRAS—lung cancer	7.69e-06	0.000115	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ALB—lung cancer	7.69e-06	0.000115	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—KRAS—lung cancer	7.52e-06	0.000112	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP1A1—lung cancer	7.4e-06	0.000111	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ERCC2—lung cancer	7.34e-06	0.00011	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PIK3CA—lung cancer	7.06e-06	0.000106	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PIK3CA—lung cancer	6.91e-06	0.000103	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—TP53—lung cancer	6.83e-06	0.000102	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PIK3CB—lung cancer	6.79e-06	0.000101	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PTGS2—lung cancer	6.73e-06	0.000101	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—TP53—lung cancer	6.69e-06	9.99e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HRAS—lung cancer	6.54e-06	9.77e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HRAS—lung cancer	6.39e-06	9.55e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—APOA1—lung cancer	6.35e-06	9.48e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IL6—lung cancer	6.26e-06	9.35e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IL6—lung cancer	6.12e-06	9.14e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PTEN—lung cancer	5.87e-06	8.77e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PIK3CG—lung cancer	5.79e-06	8.66e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—AKT1—lung cancer	5.77e-06	8.62e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—AKT1—lung cancer	5.65e-06	8.44e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—EP300—lung cancer	5.6e-06	8.36e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—POMC—lung cancer	5.51e-06	8.24e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CREBBP—lung cancer	5.37e-06	8.03e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PIK3CD—lung cancer	5.09e-06	7.61e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ALB—lung cancer	5.03e-06	7.51e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PIK3CB—lung cancer	4.44e-06	6.63e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PTGS2—lung cancer	4.4e-06	6.57e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PIK3CA—lung cancer	4.14e-06	6.18e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PTEN—lung cancer	3.84e-06	5.73e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—EP300—lung cancer	3.66e-06	5.47e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—AKT1—lung cancer	3.38e-06	5.05e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PIK3CA—lung cancer	2.71e-06	4.04e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—AKT1—lung cancer	2.21e-06	3.3e-05	CbGpPWpGaD
